Growblox Sciences Inc. (GBLX) 0.3799 $GBLX
GrowBLOX Sciences Provides Update on its Grow and Dispensary Efforts in Nevada
ACCESSWIRE - Wed Dec 17, 8:00AM CST
LAS VEGAS, NV / ACCESSWIRE / December 17, 2014 / GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, is pleased to update its shareholders on its efforts to receive the necessary licenses to grow and dispense medical cannabis in Nevada.
GrowBLOX Sciences Provides Update on its Cultivation Plans in Las Vegas
ACCESSWIRE - Tue Dec 16, 1:14PM CST
Recently Received Nevada State Approval Targets a 1st Half 2015 Start-Up Date for Commercialization
GrowBLOX Sciences Appoints Cathryn Kennedy as CFO
GlobeNewswire - Tue Dec 09, 2:25PM CST
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a company that focuses on plant biology and cultivation technology in order to optimize safe and consistent medical cannabis, today announced the appointment of Cathryn Kennedy as its Chief Financial Officer, effective immediately.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 68.08 (+1.82), FULL: 4.76 (-0.01)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 68.08 (+1.82)
GB Sciences and NRC Research Institute Apply Crowdsourcing and Big Data Analytics to the Discovery and Validation of Cannabis-Based Therapies
GlobeNewswire - Mon Nov 10, 5:23AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, and NRC Research Institute ("NRC"
announce the joint development of a crowdsourcing application to discover cannabis-based therapeutic combinations that are effective in the treatment of serious disorders. The app uses real-time patient feedback, impairment testing, and biometric measurements to assess the efficacy of therapeutic products made with prescreened cannabis strains.
GB Sciences and MJ Freeway Collaborate on Cannabis Patient Care and Commerce App
GlobeNewswire - Fri Nov 07, 4:59AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis, has joined forces with cannabis industry enterprise software leader MJ Freeway to develop a breakthrough app which will enhance the medical cannabis patient experience. The free downloadable software will empower patients to register, make purchases, schedule pickup orders and--where available--request delivery of GB Sciences products.
GrowBLOX Sciences Receives Nevada State Approval for Cultivation of Cannabis-Based Therapies in Las Vegas
GlobeNewswire - Thu Nov 06, 5:30AM CST
GrowBLOX Sciences, Inc., ("GB Sciences" (OTCQB:GBLX), announced today that its majority-controlled Nevada applicant, GB Sciences Nevada, LLC, has received Nevada State approval to proceed with its special use permit to establish and operate a medical marijuana cultivation facility in Clark County.
Cannabinoid Science Advancements Fuel Latest Clinical Trial Developments for Efficacy of CBD Therapies and Patents - Company Enters Stage 2 Of Trials for Cannabinoid Compounds
PR Newswire - Tue Nov 04, 7:15AM CST
Demand for cannaboid-CBD-based products rising in US as cannabis - medical marijuana movement continues forward. Sector being closely monitored as U.S. elections take place today. Cannabis Companies in focus today are: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc (NASDAQ: GWPH), Growblox Sciences, Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP) and Terra Tech Corp. (OTC: TRTC)
GWPH: 68.08 (+1.82)
GB Sciences Hosts First Medical Cannabis Conference in San Juan, Puerto Rico
GlobeNewswire - Mon Nov 03, 5:01AM CST
GB Sciences (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, will host its first annual medical cannabis conference on November 14th.
Adaptable Technology Cements Path for Revolutionary Opportunities in Cannabis Industry As Sector Attracts Major Attention Ahead of U.S. Elections
PR Newswire - Thu Oct 30, 7:45AM CDT
Heavy demand continues for Marijuana industry specific technology and climate control services for Cannabis operations as more U.S. states move towards legalization and acceptance with approaching elections. Companies in focus today are: Surna Inc. (OTC: SRNA), Growblox Sciences Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP), GreenGro Technologies Inc. (OTC: GRNH) and Medical Marijuana Inc. (OTC: MJNA)
GB Sciences Names Five New Members to Scientific Advisory Board
GlobeNewswire - Tue Oct 14, 5:00AM CDT
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a cannabinoid therapy research and development firm, has released the names of five doctors joining its scientific advisory board. Chaired by GB Sciences' Chief Science Officer Andrea Small-Howard, PhD, MBA, new board members include: John Abroon, MD; Alfredo L. Axtmayer, MD; Daniel Chueh, MD; Tony Ortiz, PhD; and Helen Turner, PhD.
GB Sciences Names Business and Public Policy Expert as Special Advisor to the CEO
GlobeNewswire - Wed Oct 01, 9:21AM CDT
GrowBLOX Sciences, Inc., a.k.a. GB Sciences (OTCQB:GBLX), a cannabinoid therapy research and development firm, has appointed Peter Emerson to serve as the senior advisor to CEO Craig Ellins. In this role, Emerson will work closely with Ellins on a wide range of policy issues primarily to ensure that treatments are uniform in purity, consistency, and potency, just like any other medicine.
GB Sciences Moves East Bringing Targeted Cannabis-Based Medicine
GlobeNewswire - Thu Sep 04, 6:01AM CDT
GrowBLOX Sciences, Inc., aka GB Sciences (OTCQB:GBLX) has expanded to the East Coast to make its brand of proprietary Cannabis-based medications available to patients in new markets. The new entity, GB Sciences East, LLC, will be headquartered in Manhattan and is moving quickly to obtain medical marijuana establishment licenses in New York, New Jersey, and New Hampshire.
*UPDATE* Big Pharma And Medical Marijuana; How Can They Coexist?
ACCESSWIRE - Mon Aug 25, 9:04AM CDT
New York, NY / ACCESSWIRE / August, 25, 2014 / Everyone has been closely following the marijuana industry. Anywhere from accessories from companies like Vapor Group Inc. (OTCQB:VPOR) to actual growing operations, this market has been a hotbed for analysis and speculation. Of course as with many developing sectors, marijuana has a long way to go before we start hearing about FDA approvals and big business taking a stand. What we have seen thus far, however, is the emergence of brand new companies mostly trading on the OTC who are becoming the mavericks of the MJ marketplace and possibly leading the way for big business and more importantly, Big Pharma to follow.
GWPH: 68.08 (+1.82), NVS: 93.91 (+0.66)
GB Sciences, Inc. CEO Craig Ellins to Present on the Medical Marijuana Stocks Public Company Panel at The Money Show: Tune in and View it Live
GlobeNewswire - Thu Aug 21, 12:00PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be presenting on the Medical Marijuana Stocks Public Company Panel at The Money Show on August 22, 2014, from 10:30am-11:30am PDT at the Hilton San Francisco Union Square. Mr. Ellins will be joined by 50+ other top industry service and product providers to discuss the emerging medical marijuana industry. The Company invites its shareholders and other interested parties to tune in and view the panel discussion live by registering for free at: http://www.moneyshow.com/eshow/san_francisco/...ode=035226
GB Sciences, Inc. Provides Update on Nevada State Licensing Applications
GlobeNewswire - Fri Aug 15, 6:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced they have completed and officially submitted 4 Nevada State license applications for 1 cultivation facility and 3 dispensaries as of August 13, 2014. The Company has already received a special use permit for a dispensary and cultivation facility in Clark County, Nevada. The special use permits issued by the County Commissioner's Office is expected to have some influence on the final State decision but does not guarantee State approval.
CSO Andrea Small-Howard, PhD of GrowBLOX Sciences, Inc. to Be Interviewed Live on Clear Channel Business Talk Radio - August 13th, 2014
Marketwire - Tue Aug 12, 9:42AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the Arrival of the First GrowBLOX(TM) Cultivation Chamber in Las Vegas, Nevada
GlobeNewswire - Mon Aug 11, 6:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced today that the first GrowBLOX(TM) cultivation chamber has arrived in Las Vegas, Nevada. With the arrival of The Company's core technology, GB Sciences will be better prepared to commence its cultivation operations in Nevada; pending the upcoming Nevada State Licensing decision. Through its local, majority-owned subsidiary, GB Sciences Nevada, LLC, GB Sciences, Inc. is awaiting final license approval for one cultivation facility in Clark County, Nevada, and three medical marijuana dispensaries, two in the City of Las Vegas and one in Clark County, Nevada. GB Sciences has already received special use permits for one dispensary and one cultivation facility issued by the Clark County Commissioner's Office. The State is expected to make their decisions as early as this month, but no later than November 3, 2014.
CSO Andrea Small-Howard PhD of GrowBLOX Sciences, Inc. to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 13th, 2014
Marketwire - Fri Aug 08, 9:12AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GrowBLOX Sciences Provides Update on its Grow and Dispensary Efforts in Nevada
ACCESSWIRE - Wed Dec 17, 8:00AM CST
LAS VEGAS, NV / ACCESSWIRE / December 17, 2014 / GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, is pleased to update its shareholders on its efforts to receive the necessary licenses to grow and dispense medical cannabis in Nevada.
GrowBLOX Sciences Provides Update on its Cultivation Plans in Las Vegas
ACCESSWIRE - Tue Dec 16, 1:14PM CST
Recently Received Nevada State Approval Targets a 1st Half 2015 Start-Up Date for Commercialization
GrowBLOX Sciences Appoints Cathryn Kennedy as CFO
GlobeNewswire - Tue Dec 09, 2:25PM CST
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a company that focuses on plant biology and cultivation technology in order to optimize safe and consistent medical cannabis, today announced the appointment of Cathryn Kennedy as its Chief Financial Officer, effective immediately.
American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST
GWPH: 68.08 (+1.82), FULL: 4.76 (-0.01)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 68.08 (+1.82)
GB Sciences and NRC Research Institute Apply Crowdsourcing and Big Data Analytics to the Discovery and Validation of Cannabis-Based Therapies
GlobeNewswire - Mon Nov 10, 5:23AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, and NRC Research Institute ("NRC"
announce the joint development of a crowdsourcing application to discover cannabis-based therapeutic combinations that are effective in the treatment of serious disorders. The app uses real-time patient feedback, impairment testing, and biometric measurements to assess the efficacy of therapeutic products made with prescreened cannabis strains. GB Sciences and MJ Freeway Collaborate on Cannabis Patient Care and Commerce App
GlobeNewswire - Fri Nov 07, 4:59AM CST
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis, has joined forces with cannabis industry enterprise software leader MJ Freeway to develop a breakthrough app which will enhance the medical cannabis patient experience. The free downloadable software will empower patients to register, make purchases, schedule pickup orders and--where available--request delivery of GB Sciences products.
GrowBLOX Sciences Receives Nevada State Approval for Cultivation of Cannabis-Based Therapies in Las Vegas
GlobeNewswire - Thu Nov 06, 5:30AM CST
GrowBLOX Sciences, Inc., ("GB Sciences"
(OTCQB:GBLX), announced today that its majority-controlled Nevada applicant, GB Sciences Nevada, LLC, has received Nevada State approval to proceed with its special use permit to establish and operate a medical marijuana cultivation facility in Clark County. Cannabinoid Science Advancements Fuel Latest Clinical Trial Developments for Efficacy of CBD Therapies and Patents - Company Enters Stage 2 Of Trials for Cannabinoid Compounds
PR Newswire - Tue Nov 04, 7:15AM CST
Demand for cannaboid-CBD-based products rising in US as cannabis - medical marijuana movement continues forward. Sector being closely monitored as U.S. elections take place today. Cannabis Companies in focus today are: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc (NASDAQ: GWPH), Growblox Sciences, Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP) and Terra Tech Corp. (OTC: TRTC)
GWPH: 68.08 (+1.82)
GB Sciences Hosts First Medical Cannabis Conference in San Juan, Puerto Rico
GlobeNewswire - Mon Nov 03, 5:01AM CST
GB Sciences (OTCQB:GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis, will host its first annual medical cannabis conference on November 14th.
Adaptable Technology Cements Path for Revolutionary Opportunities in Cannabis Industry As Sector Attracts Major Attention Ahead of U.S. Elections
PR Newswire - Thu Oct 30, 7:45AM CDT
Heavy demand continues for Marijuana industry specific technology and climate control services for Cannabis operations as more U.S. states move towards legalization and acceptance with approaching elections. Companies in focus today are: Surna Inc. (OTC: SRNA), Growblox Sciences Inc. (OTC: GBLX), Hemp, Inc. (OTC: HEMP), GreenGro Technologies Inc. (OTC: GRNH) and Medical Marijuana Inc. (OTC: MJNA)
GB Sciences Names Five New Members to Scientific Advisory Board
GlobeNewswire - Tue Oct 14, 5:00AM CDT
GrowBLOX Sciences, Inc., "GB Sciences" (OTCQB:GBLX), a cannabinoid therapy research and development firm, has released the names of five doctors joining its scientific advisory board. Chaired by GB Sciences' Chief Science Officer Andrea Small-Howard, PhD, MBA, new board members include: John Abroon, MD; Alfredo L. Axtmayer, MD; Daniel Chueh, MD; Tony Ortiz, PhD; and Helen Turner, PhD.
GB Sciences Names Business and Public Policy Expert as Special Advisor to the CEO
GlobeNewswire - Wed Oct 01, 9:21AM CDT
GrowBLOX Sciences, Inc., a.k.a. GB Sciences (OTCQB:GBLX), a cannabinoid therapy research and development firm, has appointed Peter Emerson to serve as the senior advisor to CEO Craig Ellins. In this role, Emerson will work closely with Ellins on a wide range of policy issues primarily to ensure that treatments are uniform in purity, consistency, and potency, just like any other medicine.
GB Sciences Moves East Bringing Targeted Cannabis-Based Medicine
GlobeNewswire - Thu Sep 04, 6:01AM CDT
GrowBLOX Sciences, Inc., aka GB Sciences (OTCQB:GBLX) has expanded to the East Coast to make its brand of proprietary Cannabis-based medications available to patients in new markets. The new entity, GB Sciences East, LLC, will be headquartered in Manhattan and is moving quickly to obtain medical marijuana establishment licenses in New York, New Jersey, and New Hampshire.
*UPDATE* Big Pharma And Medical Marijuana; How Can They Coexist?
ACCESSWIRE - Mon Aug 25, 9:04AM CDT
New York, NY / ACCESSWIRE / August, 25, 2014 / Everyone has been closely following the marijuana industry. Anywhere from accessories from companies like Vapor Group Inc. (OTCQB:VPOR) to actual growing operations, this market has been a hotbed for analysis and speculation. Of course as with many developing sectors, marijuana has a long way to go before we start hearing about FDA approvals and big business taking a stand. What we have seen thus far, however, is the emergence of brand new companies mostly trading on the OTC who are becoming the mavericks of the MJ marketplace and possibly leading the way for big business and more importantly, Big Pharma to follow.
GWPH: 68.08 (+1.82), NVS: 93.91 (+0.66)
GB Sciences, Inc. CEO Craig Ellins to Present on the Medical Marijuana Stocks Public Company Panel at The Money Show: Tune in and View it Live
GlobeNewswire - Thu Aug 21, 12:00PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be presenting on the Medical Marijuana Stocks Public Company Panel at The Money Show on August 22, 2014, from 10:30am-11:30am PDT at the Hilton San Francisco Union Square. Mr. Ellins will be joined by 50+ other top industry service and product providers to discuss the emerging medical marijuana industry. The Company invites its shareholders and other interested parties to tune in and view the panel discussion live by registering for free at: http://www.moneyshow.com/eshow/san_francisco/...ode=035226
GB Sciences, Inc. Provides Update on Nevada State Licensing Applications
GlobeNewswire - Fri Aug 15, 6:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced they have completed and officially submitted 4 Nevada State license applications for 1 cultivation facility and 3 dispensaries as of August 13, 2014. The Company has already received a special use permit for a dispensary and cultivation facility in Clark County, Nevada. The special use permits issued by the County Commissioner's Office is expected to have some influence on the final State decision but does not guarantee State approval.
CSO Andrea Small-Howard, PhD of GrowBLOX Sciences, Inc. to Be Interviewed Live on Clear Channel Business Talk Radio - August 13th, 2014
Marketwire - Tue Aug 12, 9:42AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the Arrival of the First GrowBLOX(TM) Cultivation Chamber in Las Vegas, Nevada
GlobeNewswire - Mon Aug 11, 6:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced today that the first GrowBLOX(TM) cultivation chamber has arrived in Las Vegas, Nevada. With the arrival of The Company's core technology, GB Sciences will be better prepared to commence its cultivation operations in Nevada; pending the upcoming Nevada State Licensing decision. Through its local, majority-owned subsidiary, GB Sciences Nevada, LLC, GB Sciences, Inc. is awaiting final license approval for one cultivation facility in Clark County, Nevada, and three medical marijuana dispensaries, two in the City of Las Vegas and one in Clark County, Nevada. GB Sciences has already received special use permits for one dispensary and one cultivation facility issued by the Clark County Commissioner's Office. The State is expected to make their decisions as early as this month, but no later than November 3, 2014.
CSO Andrea Small-Howard PhD of GrowBLOX Sciences, Inc. to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 13th, 2014
Marketwire - Fri Aug 08, 9:12AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
